GET DAILY SIGNALSBlaize Holdings (BZAI): Charting a Path Toward the $0.95 Price Target and +115% Upside
Key Takeaways
- The central target of $0.95 is the arithmetic mean of four verified analyst price targets ($0.35, $0.40, $1.00, and $2.00), with a low-to-high range of $0.35 to $2.00.
- With the stock trading near $0.44, reaching $0.95 would require roughly 115% upside, a very large move.
- The analyst range is unusually wide, signaling deep disagreement about execution risk and the company's near-term revenue trajectory.
- Strongest supports include the company's energy-efficient GSP (Graph Streaming Processor) architecture and a NeoTensr contract worth up to $50 million.
- Biggest risks include collapsing revenue, repeated guidance cuts, extreme customer concentration, dilution, and an auditor's going-concern note.
What the Analyst Targets Reveal
Four current, individually attributable price targets form the basis of the central target. DA Davidson's Gil Luria downgraded the stock to Neutral and cut his target to $1.00 from $3.00 in August 2026. B. Riley Securities' Craig Ellis kept a Buy rating but lowered his target to $2.00 from $4.00. After the company pre-announced a third-quarter revenue shortfall in early October 2026, Rosenblatt downgraded the stock to Neutral with a $0.40 target (from $2.00), and Craig-Hallum downgraded it to Hold with a $0.35 target. The mean of these four targets is about $0.94, rounded to a central target of $0.95. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
This is not a published consensus figure; it is a calculated average of the verified targets reviewed. The wide $0.35-to-$2.00 range reflects how differently analysts weigh the company's near-term liquidity and shipment timing against its longer-term edge-AI opportunity. The cautious sub-$0.50 targets emphasize limited cash and doubts about fulfilling the NeoTensr contract, while the $2.00 target assumes execution recovers.
Current Market Position and Path Toward the Target
The shares traded near $0.44 in early October 2026, close to the 52-week low of $0.42 and far below the 52-week high of $6.76. Reaching $0.95 would require roughly a 115% advance, which is a very large move by any standard and would likely require a fundamental reset in investor expectations rather than a routine re-rating. From what I see, the path is complicated by a steep revenue decline. The company guided preliminary first-quarter 2026 revenue of about $2.7 million, then pre-announced third-quarter 2026 revenue of roughly $0.5 million and revised full-year 2026 guidance down to $32 million to $36 million, reflecting shipment timing and working-capital constraints. A move toward $0.95 would most plausibly depend on credible delivery against the NeoTensr orders and evidence that cash burn is stabilizing.
Factors That Could Support a Move Toward the Target
- The NeoTensr agreement, announced in April 2026, contemplates up to $50 million in first-year revenue, on top of $23.8 million earned from a prior NeoTensr order in the fourth quarter of 2025.
- Blaize's GSP architecture targets AI inference workloads where low latency and power efficiency matter, positioning it in edge-AI, computer vision, and mission-critical applications.
- The April 2026 launch of Blaize AI Services aims to convert infrastructure into recurring AI-service revenue, which could diversify income beyond hardware sales.
- A BlackRock stake disclosed in September 2026 suggested some institutional interest in the longer-term AI-computing story.
Risks That Could Keep the Target Out of Reach
- Revenue has collapsed: preliminary Q3 2026 revenue of roughly $0.5 million and a full-year guide cut to $32 million to $36 million underscore severe execution and supply-chain headwinds.
- Customer concentration is extreme — two China-based customers accounted for 61% and 27% of 2025 revenue, and key contracts lack minimum purchase commitments.
- The UAE defense POCA (Purchase Order Contract Agreement), worth up to $104 million, has generated no revenue and no shipments through early 2026.
- Dilution and financing risk are material, including a $250 million shelf registration, a May 2026 equity offering at $1.85 per share, and an auditor's going-concern note.
Technical Levels and Market Structure
The stock sits near its 52-week low of $0.42, deep in a prolonged downtrend from the $6.76 high. The $1.00 level is a notable psychological and prior-analyst-target zone that would need to be reclaimed before the $0.95 central target could be approached with confidence. Below current levels, the $0.42 low and the $0.35-to-$0.40 analyst targets represent the nearest downside reference points. I'm watching this closely for any signs of stabilization.
Time Horizon and What Investors Should Monitor
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms rarely publish a uniform timeline. Key items to watch include the next earnings report (estimated for November 12, 2026), fourth-quarter shipment and NeoTensr fulfillment progress, cash position and any additional financing, customer order flow, and further analyst revisions. Revenue recognition depends heavily on fourth-quarter shipments and customer payments, so any delay could materially shift the outlook.
Using AI Tools in My Research Process
In my view, tools like Tickeron’s AI Daily Buy/Sell Signals help monitor volatile names such as BZAI by generating signals based on technical behavior and market conditions. This allows for more efficient tracking of shifting trends alongside traditional analysis.
Final Assessment
The $0.95 central target is a calculated average of four verified analyst price targets spanning $0.35 to $2.00, not a assure or a published consensus. From a price near $0.44, it represents roughly 115% upside — a very large move that would require the company to reverse its recent revenue collapse, demonstrate credible delivery against the NeoTensr contract, and stabilize its cash position. Supportive factors include the edge-AI architecture and the up-to-$50 million NeoTensr opportunity, while the principal obstacles are guidance cuts, extreme customer concentration, dilution, and a going-concern flag. With several analysts now holding sub-$0.50 targets and one Buy-rated analyst at $2.00, investors should watch fourth-quarter shipments, cash levels, and upcoming earnings before drawing conclusions.
Exploring Tickeron AI Tools for Deeper Insights
One thing that stands out in my own process is how Tickeron’s AI Daily Buy/Sell Signals can complement fundamental research on stocks like BZAI. By continuously scanning market data and generating actionable signals, the platform helps identify potential entry or exit points more efficiently. I have found it useful for staying on top of technical shifts in high-volatility names, especially when combined with earnings updates and contract news. This approach keeps the analysis grounded while adding a layer of data-driven perspective to the overall picture.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BZAI's Indicator enters downward trend
The Aroon Indicator for BZAI entered a downward trend on November 04, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 114 similar instances where the Aroon Indicator formed such a pattern. In 96 of the 114 cases the stock moved lower. This puts the odds of a downward move at 84%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BZAI as a result. In 30 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 36%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BZAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BZAI's RSI Indicator exited the oversold zone, 12 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for BZAI just turned positive on October 22, 2026. Looking at past instances where BZAI's MACD turned positive, the stock continued to rise in 15 of 49 cases over the following month. The odds of a continued upward trend are 31%.
Following a +11.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where BZAI advanced for three days, in 80 of 133 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
BZAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.693) is normal, around the industry mean (-1.906). P/E Ratio (-0.353) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.395) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. BZAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BZAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement